Published: 4. January, 2024
Link to release: (Link to Q&A session-image)
Link to release: (Link to Q&A session-image)
Related articles
Releases
13. November, 2025
Financial Report Q3-2025
The Company has advanced well with its planned activities Closing the clinical and regulatory...
Releases
31. October, 2025
CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children
Successful completion of technology transfer of CT001 with STAQ Pharma supporting near term product...
Releases
21. August, 2025
Financial Report Q2-2025
The Company has advanced well with its planned activities Positive and clinical meaningful top-line...